A novel TetR-regulating peptide turns off rtTA-mediated activation of gene expression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24810590.
- Also identified by DOI 10.1371/journal.pone.0096546 and PMC identifier 4014509.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Conditional regulation of gene expression is a powerful and indispensable method for analyzing gene function. The "Tet-On" system is a tool widely used for that purpose. Here, the transregulator rtTA mediates expression of a gene of interest after addition of the small molecule effector doxycycline. Although very effective in rapidly turning on gene expression, the system is hampered by the long half-life of doxycycline which makes shutting down gene expression rapidly very difficult to achieve. We isolated an rtTA-binding peptide by in vivo selection that acts as a doxycycline antagonist and leads to rapid and efficient shut down of rtTA-mediated reporter gene expression in a human cell line. This peptide represents the basis for novel effector molecules which complement the "Tet-system" by enabling the investigator to rapidly turn gene expression not just on at will, but now also off.
Medical subject headings
- Peptides
- Repressor Proteins
- Transcriptional Activation